JP Morgan Private Wealth Advisors’s PLx Pharma PLXP Stock Holding History
Bought
Maintained
Sold
Other funds holding PLXP
GSC
JP Morgan Private Wealth Advisors's PLXP Position: Q4 2022 in Review
JP Morgan Private Wealth Advisors sold out of PLx Pharma (PLXP) in Q4 2022, closing a stake of 29,962 shares — an estimated $19K sold.
JP Morgan Private Wealth Advisors first reported a position in PLXP in Q2 2021 and held it in 6 quarters. The position peaked at $4.12M in Q3 2021. 41 funds tracked by Wall St. Rank hold PLXP as of Q4 2022.
- JP Morgan Private Wealth Advisors reported no remaining PLx Pharma position as of Q4 2022 after selling out during the quarter.
- JP Morgan Private Wealth Advisors sold 29,962 PLx Pharma shares in Q4 2022, an estimated $19K.
- JP Morgan Private Wealth Advisors first reported a position in PLx Pharma in Q2 2021 and held it in 6 quarters.
- JP Morgan Private Wealth Advisors's PLx Pharma position peaked at $4.12M in Q3 2021.
- 41 funds tracked by Wall St. Rank held PLx Pharma as of Q4 2022.
Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.